The study suggested that the subgroup with PLA2R SAb−/GAg− shared a similar renal disease course with PLA2R-related PMN, while those with PLA2R SAb−/GAg− were more prone to developing adverse events such as cancer and death during follow-up. The gene discussed is PLA2R1; the disease is cancer.